Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Creating a Risk-Based
CAPA Process
ISO 13485,
ISO
Clause 8.5.2 /
14971
8.5.3
Mngt. Review
Effectiveness CAPA’s
MAUDE
Clinicals Service
NCMR’s
VOC Surveys
Complaints
Internal Audits
Mngt. Review
Effectiveness CAPA’s
MAUDE
Clinicals Service
Why Risk-Based?
• 21 CFR 820 – 1 instance of the word “risk”
• ISO 9001:2008 – 3 instances of the word “risk”
• ISO 9001:2015 – 43 instances of the word “risk”
• ISO 13485:2003 – 4 instances of the word “risk”
• ISO 13485:2015 – 47 instances of the word “risk”
14971 Plus =
Standard + Gap + Bonus Tools
6 – Risk Control
Risk
7 – Residual Risk Management
Acceptability
8 – Risk Management
Report
9 – Production &
Post-production Info
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Slide 9 of 28
Risk
Analysis
Trend Quality
Analysis Plan
Formal
Rob Packard, President
CAPA www.MedicalDeviceAcademy.com
rob@13485cert.com
Slide 10 of 28
21 CFR 820.100
a) Each manufacturer shall establish and maintain procedures for implementing corrective and preventive
action. The procedures shall include requirements for:
1) Analyzing processes, work operations, concessions, quality audit reports, quality records, service
records, complaints, returned product, and other sources of quality data to identify existing and
potential causes of nonconforming product, or other quality problems. Appropriate statistical
methodology shall be employed where necessary to detect recurring quality problems;
2) Investigating the cause of nonconformities relating to product, processes, and the quality system;
3) Identifying the action(s) needed to correct and prevent recurrence of nonconforming product and
other quality problems;
4) Verifying or validating the corrective and preventive action to ensure that such action is effective
and does not adversely affect the finished device;
5) Implementing and recording changes in methods and procedures needed to correct and prevent
identified quality problems;
6) Ensuring that information related to quality problems or nonconforming product is disseminated
to those directly responsible for assuring the quality of such product or the prevention of such
problems; and
7) Submitting relevant information on identified quality problems, as well as corrective and
preventive actions, for management review.
b) All activities required under this section, and their results, shall be documented.
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Slide 17 of 28
Risk Controls
• Inspection – 21 CFR 820.80
21 CFR 820.250
Statistical Techniques
a) Where appropriate, each manufacturer shall establish
and maintain procedures for identifying valid statistical
techniques required for establishing, controlling, and
verifying the acceptability of process capability and
product characteristics.
b) Sampling plans, when used, shall be written and based
on a valid statistical rationale. Each manufacturer shall
establish and maintain procedures to ensure that
sampling methods are adequate for their intended use
and to ensure that when changes occur the sampling
plans are reviewed. These activities shall be
documented.
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Slide 20 of 28
CAPA CAPA
Opened Closed
Risk Control
Rob Packard, President
Option Analysis www.MedicalDeviceAcademy.com
22
rob@13485cert.com
Slide 23 of 28
http://medicaldeviceacademy.com/5- http://medicaldeviceacademy.com/imple
ways-improve-capa-process/ menting-risk-management-process-
compliant-iso-149712007-address-seven-
deviations-identified-en-iso-149712012/
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Slide 27 of 28
Q&A
rob@13485cert.com
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Slide 28 of 28
rob@13485cert.com
+1.802.281.4381
Rob Packard